The latest report entitled ‘Non-alcoholic Steatohepatitis Market’ by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe.
The global non-alcoholic steatohepatitis market, or NASH drugs market, is valued at USD 7.48 billion in 2024 and is poised to reach at USD 71.69 billion...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek